OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc.

TSE:4564.T

Overview | Financials
Company Name OncoTherapy Science, Inc.
Symbol 4564.T
Currency JPY
Price 37
Market Cap 10,050,826,113
Dividend Yield 0%
52-week-range 15 - 64
Industry Biotechnology
Sector Healthcare
CEO Junichi Shimada
Website https://www.oncotherapy.co.jp

An error occurred while fetching data.

About OncoTherapy Science, Inc.

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I

Related Stocks

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,930 JPY

MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370.T

46 JPY

SEED Co.,Ltd. logo

SEED Co.,Ltd.

7743.T

507 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

437 JPY

Solasia Pharma K.K. logo

Solasia Pharma K.K.

4597.T

48 JPY

JTEC Corporation logo

JTEC Corporation

3446.T

1,560 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,421 JPY

JMS Co.,Ltd. logo

JMS Co.,Ltd.

7702.T

501 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

396 JPY

Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

526 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD